Mirati Therapeutics, Inc.

ProShare Advisors LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

4,482

Value ($000)

263

Weight

0.0%

2019 Q4 - 2023 Q4 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	263	0.0%	4,482	12/31/2023
2022 Q4	2/2/2023	251	0.0%	5,550	12/31/2022
2022 Q3	11/7/2022	383	0.0%	5,475	9/30/2022
2022 Q2	8/1/2022	345	0.0%	5,144	6/30/2022
2022 Q1	5/10/2022	565	0.0%	6,877	3/31/2022
2021 Q4	2/8/2022	1,324	0.0%	9,026	12/31/2021
2021 Q3	11/12/2021	2,143	0.0%	12,115	9/30/2021
2021 Q2	8/13/2021	1,493	0.0%	9,243	6/30/2021
2021 Q1	5/14/2021	3,159	0.0%	18,439	3/31/2021
2020 Q4	2/9/2021	3,785	0.0%	17,235	12/31/2020
2020 Q3	11/13/2020	1,955	0.0%	11,775	9/30/2020
2020 Q2	8/3/2020	1,367	0.0%	11,971	6/30/2020
2020 Q1	5/15/2020	551	0.0%	7,166	3/31/2020
2019 Q4	2/12/2020	1,575	0.0%	12,220	12/31/2019